/

Investors / Germany / Nucleus Capital

Nucleus Capital

Venture capital · Berlin, Germany · Europe

nucleus-capital.comTakes pitches from founders

Nucleus Capital is a first-check investor that backs technical teams at the earliest stage. It makes checks of up to €1.0M, leading or co-leading, and supports scientific ventures with a concentrated portfolio active in Europe and the US.

Invests inAI & Machine LearningHealthcare & BiotechIndustrial & Manufacturing

In its own wordsdeep techprogrammable biologyfood technologyindustrial technologyfrontier techsustainability

Your fit with Nucleus Capital

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
18portfolio companies
6funding rounds on record1 led
5rounds, last 12 months
$5M to $20Mtypical round it comes in at
Seedmost frequent entry

Nucleus Capital lists 18 checked portfolio companies on its own site and is named in 6 funding rounds, 1 of them as lead. Its most frequent entry is Seed, 50% of the companies with a known first round. Its largest themes are AI & Machine Learning (36%), Healthcare & Biotech (19%) and Industrial & Manufacturing (19%). 58% of its companies are based in Germany. It invests most often alongside Founders Factory, Possible Ventures and Robin Capital.

Counts come from funding rounds that name Nucleus Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.

Round figures show recent activity, not Nucleus Capital's whole history. Rounds on record name 6 companies; its own site lists 18. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.

Entry stage

share of companies by the stage of its first round
Show as a table
Share of companies by the stage of the firm's first round
Value
Pre-seed17%
Seed50%
Series A33%
Series B0%
Growth0%

Activity by year

rounds it joined, last 10 years
Show as a table
Funding rounds per year
TotalRounds it led
'1700
'1800
'1900
'2000
'2100
'2200
'2300
'2400
'2521
'2640

Investor profile

percentile among all firms
Portfolio size: 18 companiesRecent activity: 5 rounds in 12 monthsEarly stage: 67% of entries at pre-seed or seedEvidence: 11% of companies confirmed by a roundSector focus: 36% in its largest sectorReach: 4 countriesPortfolio size46th pctRecent activity86th pctEarly stage80th pctEvidence80th pctSector focus65th pctReach70th pct
This firmMedian of all firms
Show as a table
Nucleus Capital compared with all firms
MeasurePercentile of all firmsValue
Portfolio size46th18 companies
Recent activity86th5 rounds in 12 months
Early stage80th67% of entries at pre-seed or seed
Evidence80th11% of companies confirmed by a round
Sector focus65th36% in its largest sector
Reach70th4 countries

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
AI & Machine Learning36%18%
Healthcare & Biotech19%15%
Industrial & Manufacturing19%7%
Food & Agriculture7%3%
Climate & Energy7%1%
Robotics & Hardware7%1%
E-commerce & Marketplaces3%6%
Education3%7%

Invests most often with

firms sharing its portfolio companies
Show as a table
Co-investors
Share
Founders Factory3
Possible Ventures3
Robin Capital3
Draper Associates2
Faber2
Fifty Years2
First Momentum2
Juniper2

All co-investors

Its portfolio companies

where they are based, and what their own sites show

Site status

  • Site answers18100%
  • No longer answers00%
  • Points to another company00%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Compare Nucleus Capital head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Recent portfolio activity

when companies last raised with Nucleus Capital
DateCompanyStage
3 Nov 2026Quint Computingquint-computing.comSeries A
28 Oct 2026EVASIVE ROBOTICSevasive-robotics.comPre-Seed
3 Jun 2026Apohaapoha.comSeries A
3 Mar 2026Bindbridgebindbridge.comSeed
15 Dec 2025Teluratelura.deSeed Led
9 Jul 2025ScienceMachinesciencemachine.aiSeed

Round details for Nucleus Capital

Amounts, full round histories and every co-investor in Nucleus Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.

See rounds on Fundup AI →

Portfolio

18 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
Apohaapoha.com · United StatesApoha teaches machines to understand matter for applications in pharma, biotech, food, and beverages
Healthcare & BiotechFood & Agriculture
Jun 2026Series APage + round
Atmioatmio.com · GermanyAtmio measures, manages, and reports methane emissions for gas infrastructure companies.
E-commerce & MarketplacesIndustrial & Manufacturing
Portfolio page
AtmoCoolingatmocooling.comAtmoCooling develops and implements large-scale microclimate cooling technology for various industries such as agriculture, energy, and infrastructure.
AI & Machine LearningAI & Machine Learning
Portfolio page
Batch Roboticsbatch-robotics.com · GermanyBatch Robotics builds a robot that can automate manufacturing tasks without needing to be programmed for each new part variant
Robotics & HardwareAI & Machine Learning
Portfolio page
Bindbridgebindbridge.com · United KingdomBindbridge discovers and designs molecular glues using AI to develop safer, more effective crop protection with novel mode of action against weeds and crop diseases.
AI & Machine LearningAI & Machine Learning
Mar 2026SeedPage + round
Biomiabiomia.comBiomia rationally engineers nature-inspired novel small molecule therapeutics to treat CNS disorders.
Healthcare & Biotech
Portfolio page
Brineworksbrineworks.tech · NetherlandsBrineworks develops and operates ultra low-cost Direct Air Capture technology to remove carbon dioxide from the air
Climate & EnergyIndustrial & Manufacturing
Portfolio page
Concert Bioconcert.bio · United KingdomConcert Bio develops microbial products to help greenhouse growers improve plant yields
AI & Machine LearningAI & Machine Learning
Portfolio page
Cultzymecultzyme.comCultzyme develops intelligent bioprocessing technology to improve biomanufacturing
Healthcare & Biotech
Portfolio page
DAFdeutsche-agrarfinanz.de · GermanyThe company provides financing and insurance services to agricultural businesses.
AI & Machine LearningAI & Machine Learning
Portfolio page
endolithendolithmining.comEndolith uses biology and machine learning to recover copper and other critical minerals from ore that conventional mining leaves behind.
Industrial & ManufacturingAI & Machine Learning
Portfolio page
EVASIVE ROBOTICSevasive-robotics.com · GermanyThe company builds backend software that lets manufacturers unlock what their robots are truly capable of
Robotics & HardwareIndustrial & Manufacturing
Oct 2026Pre-SeedFunding round
Biographicagraphica.bio · United KingdomBiographica is a biotechnology company that designs and develops better plant traits using AI and rapid experimentation.
Healthcare & Biotech
Portfolio page
Planet-A-Foodsplanet-a-foods.com · GermanyPlanet A Foods supplies food ingredient alternatives for climate-threatened and highly regulated raw materials using a fermentation platform.
Food & AgricultureClimate & Energy
Portfolio page
Quint Computingquint-computing.com · GermanyQuint Computing builds fault-tolerant quantum computers with efficiency and speed to unlock industrial impact.
Industrial & ManufacturingAI & Machine Learning
Nov 2026Series AFunding round
ScienceMachinesciencemachine.ai · United StatesScienceMachine automates workflows for bioanalytical labs using AI
Healthcare & Biotech
Jul 2025SeedFunding round
Teluratelura.de · GermanyTelura unlocks geothermal energy at scale to supply clean, emission-free energy
EducationIndustrial & Manufacturing
Dec 2025SeedFunding round
Yuriyurigravity.comYuri develops research hardware and mission solutions that enable scientists and life-science companies to investigate biology under altered-gravity conditions.
Healthcare & Biotech
Portfolio page

About this data

site last read 12 Nov 2026
The homepage of Nucleus Capital, as last read
nucleus-capital.com as VCinfo last read it
Site
nucleus-capital.com
Last read
12 Nov 2026
Watching since
5 Nov 2026
Rounds since
9 Jul 2025
Companies checked
18

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get Nucleus Capital's profile as data

Pull Nucleus Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/nucleus-capital.com

# also
GET /v1/firms/nucleus-capital.com/portfolio
GET /v1/firms/nucleus-capital.com/coinvestors
GET /v1/firms/nucleus-capital.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing